Serum Institute of India: Covishield (Oxford/AstraZeneca formulation)

Vaccine Type: Non Replicating Viral Vector

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

This vaccine is the same formulation as the Oxford/AstraZeneca vaccine (AZD1222)

Registered Trials